high INtensity Interval Training In pATiEnts with intermittent claudication (INITIATE): protocol for a multi-centre, proof-of-concept, prospective interventional study
Pymer, Sean; Harwood, Amy; Ibeggazene, Said; McGregor, Gordon; Huang, Chao; Twiddy, Maureen; Nicholls, Adam R.; Ingle, Lee; Carroll, Sean; Long, Judith; Rooms, Marjorie; Chetter, I. C.
Dr Chao Huang C.Huang@hull.ac.uk
Senior Lecturer in Statistics
Dr Maureen Twiddy M.Twiddy@hull.ac.uk
Senior Lecturer in Mixed Methods Research
Professor Adam Nicholls A.Nicholls@hull.ac.uk
Professor of Psychology/ Leader of the Sport Psychology and Coaching Group
Professor Lee Ingle L.Ingle@hull.ac.uk
Professor Sean Carroll S.Carroll@hull.ac.uk
Professor of Sport, Health and Exercise Science
I. C. Chetter
Introduction: The first-line recommended treatment for patients with intermittent claudication (IC), is a supervised exercise programme (SEP), which includes a minimum of 2 hours exercise per week over a 12-week period. However, provision, uptake, and adherence rates for these SEP programmes are poor, with time constraints cited as a common participant barrier. High-intensity interval training (HIIT) is more time-efficient and therefore has the potential to overcome this barrier. However, evidence is lacking for the role of HIIT in those with IC. This proof-of-concept study aims to consider the safety, feasibility, tolerability, and acceptability of a HIIT programme for patients with IC.
Methods and analysis: This multi-centre, single-group, prospective, interventional feasibility study will recruit 40 patients with IC, who will complete 6 weeks of HIIT, 3 times a week. HIIT will involve a supervised programme of 10x 1-minute high-intensity cycling intervals at 85-90% peak power output (PPO), interspaced with 10x 1-minute low intensity intervals at 20-25% PPO. PPO will be determined from a baseline cardiopulmonary exercise test (CPET) and it is intended that patients will achieve ≥85% of maximum heart rate from CPET, by the end of the second HIIT interval. Primary outcome measures are safety (occurrence of adverse events directly related to the study), programme feasibility (including participant eligibility, recruitment and completion rates) and HIIT tolerability (ability to achieve and maintain the required intensity). Secondary outcomes include patient acceptability, walking distance, CPET cardiorespiratory fitness measures and quality of life outcomes.
Ethics and dissemination: Ethical approval was obtained via a local NHS research ethics committee (Bradford Leeds – 18/YH/0112) and recruitment began in August 2019 and will be completed in October 2020. Results will be published in peer-reviewed journals and presented at international conferences and are expected to inform a future pilot randomised controlled trial of HIIT versus usual-care SEPs.
Pymer, S., Harwood, A., Ibeggazene, S., McGregor, G., Huang, C., Twiddy, M., …Chetter, I. C. (2020). high INtensity Interval Training In pATiEnts with intermittent claudication (INITIATE): protocol for a multi-centre, proof-of-concept, prospective interventional study. BMJ open, 10(7), https://doi.org/10.1136/bmjopen-2020-038825
|Journal Article Type||Article|
|Acceptance Date||Apr 15, 2020|
|Online Publication Date||Jul 6, 2020|
|Deposit Date||Apr 16, 2020|
|Publicly Available Date||Apr 16, 2020|
|Publisher||BMJ Publishing Group|
|Peer Reviewed||Peer Reviewed|
|Keywords||Vascular surgery; Rehabilitation medicine; Vascular medicine|
©2020 The authors. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder
Publisher Licence URL
© Author(s) (or their employer(s)) 2020. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Published by BMJ.
You might also like
Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins